Hatake Kiyohiko | Division Of Medical Oncology Cancer Institute Hospital

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Increased incidence of interstitial pneumonia by CHOP combined with rituximab
A Case of Acute Promyelocytic Leukemia during Gefitinib Treatment
Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer : cross-resistance to capecitabine
Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients
Does Lapatinib, a Small-Molecule Tyrosine Kinase Inhibitor, Constitute a Breakthrough in the Treatment of Breast Cancer?
Efficacy and Safety of Combined Trastuzumab and Paclitaxel Therapy as a Second-Line Treatment in Women with Metastatic Breast Cancer : A Single Institutional Experience
High Prevalence of HER-2/neu and p53 Overexpression in Inflammatory Breast Cancer
Severe Infusion Reaction Induced by Trastuzumab : A Case Report
High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families
Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
Next Generation Molecular Targeted Agents for Breast Cancer : Focus on EGFR and VEGFR Pathways
Chemotherapy for Small-Bowel Adenocarcinoma at a Single Institution
Autophagy and autophagic cell death are next targets for elimination of the resistance to tyrosine kinase inhibitors
Modified irinotecan plus bolus 5-fluorouracil/L-leucovorin for metastatic colorectal cancer at a single institution in Japan
Continuous treatment of bestatin induces anti-angiogenic property in endothelial cells
Differential Regulation of Eotaxin-1/CCL11 and Eotaxin-3/CCL26 Production by the TNF-α and IL-4 Stimulated Human Lung Fibroblast(Pharmacology)
Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to complement-dependent cytotoxicity with rituximab
Gene Therapy for Breast Cancer.-Review of Clinical Gene Therapy Trials for Breast Cancer and MDR1 Gene Therapy Trial in Cancer Institute Hospital
No CD117 expression on B progenitors in the regenerating bone marrow
Rare but important adverse effects of all-trans retinoic acid in acute promyelocytic leukemia and their management
Philadelphia chromosome-negative cells with trisomy 8 after busulfan and interferon treatment of Ph^1-positive chronic myelogenous leukemia
Functional in vivo optical imaging of tumor angiogenesis, growth, and metastasis prevented by administration of anti-human VEGF antibody in xenograft model of human fibrosarcoma HT1080 cells
Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes
Complete Resection After Imatinib Treatment of a Gastrointestinal Stromal Tumor of the Ileum with Peritoneal Metastases : Report of a Case
Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency
Anal Canal Carcinoma with Pagetoid Spread : Report of a Case
Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer
Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer
Predictors of the Efficacy of FOLFIRI plus Bevacizumab as Second-Line Treatment in Metastatic Colorectal Cancer Patients
Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients
Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant anthracycline and taxane
Phase I study of dasatinib (BMS-354825) in Japanese patients with solid tumors
5. Tanstuzumab Treatment for Breast Cancer

もっと見る

スポンサーリンク